Differentiation of Campylobacter jejuni serotype O19 strains from non- O19 strains by PCR

Journal of Clinical Microbiology

Volumn 36, Issue 12, 1998, Pages 3567-3573

  Misawa, Naoaki ^a   Allos, Ban Mishu ^a   Blaser, Martin J ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; LIPOPOLYSACCHARIDE;

ARTICLE; BINDING SITE; CAMPYLOBACTER JEJUNI; GENE AMPLIFICATION; GENE SEQUENCE; GUILLAIN BARRE SYNDROME; HYPOTHESIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PARALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

CAMPYLOBACTER JEJUNI; HELICOBACTER PYLORI;

EID: 0031753016     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.12.3567-3573.1998     Document Type: Article

References (43)

1. Akopyanz, N., N. O. Bukanov, T. U. Westblom, S. Kresovich, and D. E. Berg. 1992. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 20:5137-5142.
2. Allos, B. M., and M. J. Blaser. 1995. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotoxin Res. 2:237-238.
3. Allos, B. M., F. T. Lippy, A. Carlsen, R. G. Washburn, and M. J. Blaser. 1998. Campylobacter jejuni strains from patients with Guillain Barré syndrome. Emerg. Infect. Dis. 4:263-268.
4. Aspinall, G. O., S. Fujimoto, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
5. Enders, U., H. Karch, K. V. Toyka, J. Heeseman, and H. P. Hartung. 1994. Campylobacter jejuni and Guillain-Barré syndrome. Ann. Neurol. 35:248-249.
6. Fadl, A. A., A. V. Nguyen, and M. I. Khan. 1995. Analysis of Salmonella enteritidis isolates by arbitrarily primed PCR. J. Clin. Microbiol. 33:987-989.
7. Fujimoto, S., B. M. Allos, N. Misawa, C. M. Patton, and M. J. Blaser. 1997. Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome. J. Infect. Dis. 176:1105-1108.
8. Fujimoto, S., N. Yuki, T. Itoh, and K. Amako. 1992. Specific serotypes of Campylobacter jejuni associated with Guillain-Barré syndrome. J. Infect. Dis. 165:183.
9. Ge, Z., and D. E. Taylor. 1997. Rapid polymerase chain reaction screening of Helicobacter pylori chromosomal point mutations. Helicobacter 2:127-131.
10. Hilton, A. C., D. Mortiboy, J. G. Banks, and C. W. Penn. 1997. RAPD analysis of environmental, food and clinical isolates of Campylobacter spp. FEMS Immunol. Med. Microbiol. 18:119-124.
11. Hughes, R. A. C., and J. H. Rees. 1997. Clinical and epidemiologic features of Guillain-Barré syndrome. J. Infect. Dis. 176(Suppl. 2):S92-S98.
12. Husmann, M., A. Feddersen, A. Steitz, C. Freytag, and S. Bhakdi. 1997. Simultaneous identification of campylobacters and prediction of quinolone resistance by comparative sequence analysis. J. Clin. Microbiol. 35:2398-2400.
13. Jacob, B. C., M. P. Hazenberg, P. A. van Doorn, H. Endtz, and F. G. A. van der Meché. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré syndrome or Miller Fisher Syndrome. J. Infect. Dis. 175:729-733.
14. Kuroki, S., T. Saida, M. Nukina, T. Haruta, M. Yoshioka, Y. Kobayashi, and H. Nakanishi. 1993. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
15. Kwok, S., D. E. Kellogg, N. McKinney, D. Spasic, L. Goda, C. Levenson, and J. J. Sninsky. 1990. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res. 18:999-1005.
16. Lam, K. M., R. Yamamoto, and A. J. DaMassa. 1995. DNA diversity among isolates of Campylobacter jejuni detected by PCR-based RAPD fingerprinting. Vet. Microbiol. 45:269-274.
17. Lastovica, A. J., E. A. Goddard, and A. C. Argent. 1997. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. J. Infect. Dis. 176(Suppl. 2):S139-S143.
18. Lior, H., D. L. Woodward, J. A. Edgar, L. J. Laroche, and P. Gill. 1982. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J. Clin. Microbiol. 15:761-768.
19. Major, J. J. G. 1992. A rapid PCR method of screening for small mutations. BioTechniques 12:40-44.
20. Mazurier, S., A. van de Giessen, K. Heuvelman, and K. Wernars. 1992. RAPD analysis of Campylobacter isolates: DNA fingerprinting without the need to purify DNA. Lett. Appl. Microbiol. 14:260-262.
21. Mishu, B., and M. J. Blaser. 1993. The role of Campylobacter jejuni infection in the initiation of Guillain-Barré syndrome. Clin. Infect. Dis. 17:104-108.
22. Moran, A. P., and D. T. O'Malley. 1995. Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotoxin Res. 2:233-235.
23. Nachamkin, I., B. M. Allos, and T. Ho. 1998. Campylobacter species and Guillain-Barré syndrome. Clin. Microbiol. Rev. 11:555-567.
24. Nachamkin, I., K. Bohachick, and C. M. Patton. 1993. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J. Clin. Microbiol. 31:1531-1536.
25. Nakanishi, H., M. Nukina, and R. Sakazaki. 1985. Serogroups of Campylobacter jejuni and C. coli, p. 70-73. In Proceedings of the Symposium on the 100th Anniversary of Japanese Society of Veterinary Medicine: Its Advance and View of Research. Japanese Society of Veterinary Medicine, Tokyo, Japan.
26. Patton, C. M., M. A. Nicholson, S. M. Ostroff, A. A. Ries, I. K. Wachsmuth, and R. V. Tauxe. 1993. Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J. Clin. Microbiol. 31:1525-1530.
27. Penner, J. L., and J. N. Hennessy. 1980. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:732-737.
28. Rees, J. H., S. E. Soudain, N. A. Gregson, and R. A. Hughes. 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1374-1379.
29. Saida, T., S. Kuroki, Q. Hao, M. Nishimura, M. Nukina, and H. Obayashi. 1997. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome. J. Infect. Dis. 176(Suppl. 2):S129-S134.
30. 3. Infect. Immun. 64:2945-2949.
31. Sambrook, J. E., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
32. Taylor, D. E., and S.-S. Chau. 1997. Cloning and nucleotide sequencing of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates. Antimicrob. Agents Chemother. 41:665-671.
33. Tomb, J.-F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzgerald, N. Lee, M. D. Adams, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
34. Wang, J. C. 1985. DNA topoisomerases. Annu. Rev. Biochem. 54:665-697.
35. Wang, Y., W. M. Huang, and D. E. Taylor. 1993. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37:457-463.
36. Welsh, J., and M. McClelland. 1990. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res. 18:7213-7218.
37. Williams, J. G. K., M. K. Hanafey, J. A. Rafalski, and S. V. Tingey. 1993. Genetic analysis using random amplified polymorphic DNA marker. Methods Enzymol. 218:704-740.
38. Wu, D. Y., L. Ugozzoli, B. K. Pal, and R. B. Wallace. 1989. Allele-specific enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell anemia. Proc. Natl. Acad. Sci. USA 86:2725-2760.
39. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
40. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Namamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
41. 1 and lipopolysaccharide from Penner serotype 19 of Campylobacter jejuni. Biomed. Res. 13:451-453.
42. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178: 1771-1775.
43. Yuki, N., T. Taki, M. Takahashi, K. Saito, T. Tai, T. Miyatake, and S. Handa. 1994. Penner serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62:2101-2103.